Skip to content

The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection

The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection: A Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02065037
Enrollment
229
Registered
2014-02-17
Start date
2014-06-30
Completion date
2015-09-30
Last updated
2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Neoplasms, Colonic Polyps

Keywords

Insufflation, Carbon Dioxide, Colonic Polyps, Colonoscopy, Randomized Controlled Trial

Brief summary

Colorectal cancer is the second most common cancer in the world and the second leading cause of cancer-related mortality. Colorectal cancers arise from precursor adenomatous polyps in a well characterized adenoma to carcinoma progression. The removal of such precursor lesions reduces colorectal cancer mortality between 30 to 50%. Colonoscopy is used for detection of neoplastic polyps but significant miss rates of such lesions are reported. Methods to reduce spasm of the colon have been investigated to increase adenoma detection rates including the use of warm water irrigation and hyoscine butyl bromide. Carbon dioxide warmed to body temperature is postulated to have spasmolytic effects. Administration of warmed carbon dioxide during colonoscopy may improve polyp detection. Objective: In this study, colonoscopy using warmed carbon dioxide insufflation will be compared to standard room temperature air insufflation to see if there is a greater detection of polyps per patient. Methods: Patients undergoing colonoscopy for screening and surveillance indications will be included and randomized to receive either room temperature room air or warmed carbon dioxide (37 degrees Celsius). Endoscopists and patients will be blinded to the intervention. Data on indication, preparation, sedation, withdrawal time will be recorded. Polyp detection rate will be the primary outcome. Secondary outcomes will include adenoma detection rate and advanced lesion detection rates.

Detailed description

study terminated

Interventions

DEVICEroom temperature air insufflation

control arm

DEVICEwarmed carbon dioxide insufflation

comparator arm

Sponsors

Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-outpatients undergoing routine screening or surveillance colonoscopy for colorectal cancer and / or polyp surveillance at Hotel Dieu Hospital

Exclusion criteria

* patients who have undergone colonic resections * active inflammatory bowel disease * hereditary polyposis syndromes * moderate to severe chronic obstructive pulmonary disease * obstructive sleep apnea requiring continuous positive airway pressure or biphasic positive airway pressure * neurologic diagnoses affecting ventilation

Design outcomes

Primary

MeasureTime frame
Polyp Detection Ratetime of endoscopy

Secondary

MeasureTime frame
adenoma detection rate2 weeks
advanced lesion per patient detection rate2 weeks

Other

MeasureTime frame
quality of bowel preparationday of colonoscopy
cecal intubation rateday of colonoscopy
patient comfort by a validated nurse administered comfort scoreday of colonoscopy
withdrawal timeday of colonoscopy
anesthetic dosesday of colonoscopy

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026